文献速递消化道肿瘤与早癌消化内镜

放大内镜联合光学增强与白光内镜检测胃黏膜肠化生及肿瘤性病变:一项随机对照试验

Optical enhancement with magnification versus white-light endoscopy for detecting gastric intestinal metaplasia and neoplasia: a randomized controlled trial.
PubMed 文献 · Gastrointest Endosc · 2025-02-15

本研究将胃癌高危患者按1:1随机分为放大内镜联合光学增强(ME-OE)组和白光内镜(WLE)组,比较两者对胃黏膜肠化生(GIM)、胃上皮内瘤变(GIN)及早期胃癌(EGC)的检出效果。最终分析285例,ME-OE组患者层面诊断率36.6%高于WLE组23.8%(P=.018),病灶层面诊断率66.7% vs 48.7%(P=.017),GIM的敏感度、阳性预测值及准确率均优于WLE。结论认为在高危人群中ME-OE检测GIM的表现优于WLE。

要点

  • ME-OE组患者层面GIM、GIN、EGC诊断率36.6%,高于WLE组23.8%(P=.018)。
  • ME-OE组病灶层面诊断率66.7%,高于WLE组48.7%(P=.017)。
  • GIM敏感度ME-OE组82.8% vs WLE组54.3%(P=.003),准确率83.3% vs 69.2%(P=.028)。

核心结论

  • 在高危人群中,ME-OE检测GIM的表现优于WLE。

研究设计与样本

  • 胃癌高危患者按1:1比例随机分配至ME-OE组或WLE组,两组对可疑GIM、GIN、EGC病灶行靶向活检,最终分析285例。

主要发现

  • 患者层面GIM、GIN、EGC诊断率ME-OE组36.6% vs WLE组23.8%(P=.018)。
  • 病灶层面GIM、GIN、EGC诊断率ME-OE组66.7% vs WLE组48.7%(P=.017)。
  • GIM敏感度ME-OE组82.8% vs WLE组54.3%(P=.003),特异度84.2% vs 81.4%(P=.738)。
  • GIM阳性预测值ME-OE组88.9% vs WLE组70.4%(P=.038),阴性预测值76.2% vs 68.6%(P=.419),准确率83.3% vs 69.2%(P=.028)。
  • 有经验内镜医师的观察者内一致性ME-OE组κ=0.81和κ=0.83(极好),WLE组κ=0.63和κ=0.62(好);观察者间一致性两组分别为κ=0.75和κ=0.61(好)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: The detection of gastric intestinal metaplasia (GIM), gastric intraepithelial neoplasia (GIN), and early gastric cancer (EGC) using white-light endoscopy (WLE) is unsatisfactory. This study assessed the value of optical enhancement combined with magnification endoscopy (ME-OE) versus WLE for detecting GIM, GIN, and EGC. METHODS: Patients at high risk for gastric cancer were randomly assigned to the ME-OE group or WLE group at a 1:1 ratio. Suspicious GIM, GIN, and EGC lesions underwent targeted biopsy sampling in both groups. The diagnostic yield, diagnostic efficacy, and agreement of suspicious lesions were compared between the 2 groups. RESULTS: Two hundred eighty-five patients were finally analyzed. The per-patient diagnostic yields of GIM, GIN, and EGC were 36.6% in the ME-OE group and 23.8% in the WLE group (P = .018). The per-lesion diagnostic yield of GIM, GIN, and EGC in the ME-OE group was higher than that in the WLE group (66.7% vs 48.7%, P = .017). Sensitivity (82.8% vs 54.3%, P = .003), specificity (84.2% vs 81.4%, P = .738), positive predictive value (88.9% vs 70.4%, P = .038), negative predictive value (76.2% vs 68.6%, P = .419), and accuracy (83.3% vs 69.2%, P = .028) for GIM were compared between the 2 groups. The intraobserver agreements of experienced endoscopists were excellent for ME-OE (κ = 0.81 and κ = 0.83) and good for WLE (κ = 0.63 and κ = 0.62). The interobserver agreements of experienced endoscopists were good for both groups (κ = 0.75 and κ = 0.61, respectively). CONCLUSIONS: ME-OE showed better performance for detecting GIM than WLE in high-risk populations. (Clinical trial registration number: NCT04411589.).

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Wan M, Li GC, Ma MJ, et al. Optical enhancement with magnification versus white-light endoscopy for detecting gastric intestinal metaplasia and neoplasia: a randomized controlled trial. Gastrointest Endosc. 2025. PMID: 39956464. doi:10.1016/j.gie.2025.02.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。